Here are the S-3 shelf registrations from SeaStar Medical Holding Corporation Warrant (ICUCW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow ICUCW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ICUCW filings page.
SeaStar Medical Holding Corporation is registering up to 1,767,784 shares of common stock for resale by selling stockholders. The shares comprise up to 854,002 shares issuable under each of the Series A and Series B warrants, plus 59,780 shares under placement agent warrants.
The Series A and Series B warrants have $3.616 per-share exercise prices; the placement agent warrants have a $4.8325 exercise price. All are immediately exercisable. Series A and placement agent warrants expire five years after the resale registration statement becomes effective, and Series B warrants expire after 18 months. SeaStar receives no proceeds from resales but could receive approximately $6.5 million if all warrants are exercised for cash; it intends to use any proceeds for general corporate purposes. The audit report on the 2025 and 2024 financial statements includes an explanatory paragraph citing substantial doubt about the company’s ability to continue as a going concern.